We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Burning Rock Biotech Ltd | LSE:BNR | London | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.35 | 0 | 01:00:00 |
TIDMBNR
Blenheim Natural Resources PLC
08 January 2018
Blenheim Natural Resources - Initiation of Coverage
Conviction Buy - initial target price 1.19p
Resources investor developing blockchain, cobalt and lithium interests which represents a potent cocktail in today's market
Blenheim is the former AIM-listed coffee roasting business Coburg Group. The original business was sold off in 2012 and new blood has since joined the boardroom to set about turning the company into a natural resources investor. This transformation shifted up a gear in 2017 and now the company has substantial interests in a series of compelling projects, some "closeology" plays and where substantial value could be added in 2018.
Key events early in the New Year, with news expected on the cobalt licences
Blenheim is awaiting news on the granting of exploration licences in Cameroon. These border the world-class Nkamouna and Mada Cobalt-Nickel Project which the government is expecting to re-tender in early 2018 and which will attract the spotlight to anything cobalt related in Cameroon.
Lithium play on the doorstep of the high grade Goulamina deposit
The company has a 30-40% interest in some Mali licences which share a border with ASX-listed Birmain's Bougouni Lithium Project with its world class Goulamina lithium deposit and AIM-listed Kodal Minerals which has been announcing some impressive lithium grades and widths.
Backing a blockchain/AI business that looks set to launch an ICO
Blenheim recently announced an investment/collaboration agreement with BrandShield to develop blockchain solutions for the resources sector and provide support for commodity focused ICOs. Both blockchain and battery metals are currently attracting rising attention from small cap investors.
Peer comparisons and earnings multiples suggest an upside of 127%
Our analysis shows that the stock is under-priced. We initiate coverage of Blenheim with an initial target price of 1.19p and Conviction Buy stance.
To download the full note visit http://www.alignresearch.co.uk/cpt-company/blenheim-natural-resources/
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAMMGGMLNMGRZM
(END) Dow Jones Newswires
January 08, 2018 02:15 ET (07:15 GMT)
1 Year Burning Rock Biotech Chart |
1 Month Burning Rock Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions